---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-012775"
form_type: "8-K"
ticker: "XLO"
cik: "0001840233"
company_name: "Xilio Therapeutics, Inc."
filed_at: "2024-09-13T23:59:59+00:00"
generated_at: "2026-05-31T05:00:14.082445+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Xilio Therapeutics receives Nasdaq deficiency notice for bid price below $1.00 per share

## Summary
- Received Nasdaq notice on Sept 10, 2024; common stock bid price below $1.00 for 30 consecutive business days.
- Has 180 calendar days until March 10, 2025 to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not compliant, may transfer to Nasdaq Capital Market for additional 180-day period, subject to other listing standards.
- Company monitoring bid price and evaluating options; no assurance regaining compliance will be achieved.

## SEC filing metadata
- accession: 0001558370-24-012775
- form_type: 8-K
- ticker: XLO
- cik: 0001840233
- company_name: Xilio Therapeutics, Inc.
- filed_at: 2024-09-13T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840233/000155837024012775/0001558370-24-012775-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840233/000155837024012775/xlo-20240910x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-012775
- JSON: https://secwatch.observer/filing/0001558370-24-012775.json
- Plain text: https://secwatch.observer/filing/0001558370-24-012775.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.